Security key
03753U106
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)
CUSIP: 03753U106
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 127,672,507
- Total 13F shares
- 40,468,785
- Share change
- +491,453
- Total reported value
- $1,025,057,247
- Put/Call ratio
- 100%
- Price per share
- $25.34
- Number of holders
- 99
- Value change
- +$17,474,333
- Number of buys
- 69
- Number of sells
- 32
Report period
Q2 2019
Institutions
99
Top holders
10
APLS full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Apellis Pharmaceuticals, Inc. SEC filings
Apellis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03753U106
Recent filing periods:
Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3%
|
3,876,974
|
$75,600,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.9%
|
3,721,032
|
$72,560,000 | — | 31 Mar 2019 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.8%
|
3,600,000
|
$70,200,000 | — | 31 Mar 2019 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
2%
|
2,579,708
|
$50,304,000 | — | 31 Mar 2019 | |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. |
13F
|
Company |
1.6%
|
2,098,581
|
$40,922,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
2,003,283
|
$39,064,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,926,566
|
$37,568,000 | — | 31 Mar 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
1,762,300
|
$34,365,000 | — | 31 Mar 2019 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
1.4%
|
1,727,829
|
$33,693,000 | — | 31 Mar 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.3%
|
1,688,663
|
$32,929,000 | — | 31 Mar 2019 | |
| venBio Partners LLC |
13F
|
Company |
1.2%
|
1,526,122
|
$29,759,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.98%
|
1,248,394
|
$24,344,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.84%
|
1,069,343
|
$20,852,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.74%
|
945,184
|
$18,431,000 | — | 31 Mar 2019 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.57%
|
731,451
|
$14,263,000 | — | 31 Mar 2019 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.55%
|
705,548
|
$13,758,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.53%
|
679,888
|
$13,258,000 | — | 31 Mar 2019 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.46%
|
589,734
|
$11,500,000 | — | 31 Mar 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.46%
|
587,381
|
$11,454,000 | — | 31 Mar 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
0.41%
|
527,700
|
$10,291,000 | — | 31 Mar 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.39%
|
500,000
|
$9,750,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
487,432
|
$9,504,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
440,032
|
$8,582,000 | — | 31 Mar 2019 | |
| Vivo Capital, LLC |
13F
|
Company |
0.3%
|
383,538
|
$7,479,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
0.28%
|
363,428
|
$7,087,000 | — | 31 Mar 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.26%
|
333,629
|
$6,506,000 | — | 31 Mar 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.25%
|
313,725
|
$6,118,000 | — | 31 Mar 2019 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.24%
|
308,992
|
$6,025,000 | — | 31 Mar 2019 | |
| Artal Group S.A. |
13F
|
Company |
0.23%
|
300,000
|
$5,850,000 | — | 31 Mar 2019 | |
| Fosun International Ltd |
13F
|
Company |
0.23%
|
294,728
|
$5,623,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
211,408
|
$4,123,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
197,618
|
$3,854,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.15%
|
192,627
|
$3,757,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
169,652
|
$3,308,000 | — | 31 Mar 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.12%
|
158,940
|
$3,099,000 | — | 31 Mar 2019 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.11%
|
135,848
|
$2,649,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
127,516
|
$2,485,000 | — | 31 Mar 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
0.09%
|
115,000
|
$2,243,000 | — | 31 Mar 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.08%
|
104,349
|
$2,034,806 | — | 31 Mar 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.07%
|
90,367
|
$1,762,000 | — | 31 Mar 2019 | |
| Swiss National Bank |
13F
|
Company |
0.06%
|
79,400
|
$1,548,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
79,155
|
$1,544,000 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.06%
|
78,549
|
$1,532,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.05%
|
66,345
|
$1,294,000 | — | 31 Mar 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
55,297
|
$1,078,000 | — | 31 Mar 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
50,900
|
$993,000 | — | 31 Mar 2019 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.04%
|
50,527
|
$985,000 | — | 31 Mar 2019 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.04%
|
49,580
|
$967,000 | — | 31 Mar 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.04%
|
48,058
|
$937,000 | — | 31 Mar 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
48,000
|
$936,000 | — | 31 Mar 2019 |
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q2 2019
As of 30 Jun 2019,
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,468,785 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Cormorant Asset Management, LP, HILLHOUSE CAPITAL ADVISORS, LTD., HILLHOUSE CAPITAL MANAGEMENT, LTD., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ORBIMED ADVISORS LLC, STATE STREET CORP, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
92
Q2 2019 holders
99
Holder diff
7
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.